EVO Labs

Latest sync: Sep 8, 2026, 8:55 AM. Source coverage currently reflects PB Evidence data.

Curated

35% off with disclosed code

Disclosed partner
Coupon code35% off

Guest-cart verified 2026-08-18: BENCHMARK took 35% off GLP-3 (R) 5mg ($49.99 → −$17.50). EVO’s public partner page advertises 20% first-order + 10% lifetime recurring commission to affiliates (not a shopper discount). A concurrent sitewide anniversary sale offers 25% via ANNIVERSARY25; BENCHMARK is modeled as the better independently verified code and is not stacked with that sale. Standing customer rate vs temporary partner boost is not yet confirmed with EVO — re-verify if the cart rate changes.

PeptideBenchmark has a disclosed affiliate relationship with EVO Labs. This does not change benchmark scores or trust ratings — it only affects outbound links and pricing-board discount modeling where applicable.

Independent evidence reviewRead the independent EVO Labs evidence review
Transparency type
Third-party-linked reports
Access pattern
Publicly inspectable
Best for

Readers who want a U.S.-shipped single-vial catalog paired with a dual-lab public certificate library that can be checked at Janoshik and Kovera.

Fulfillment

Vendor-stated: orders fulfill from Tampa, Florida (8270 Woodland Center Blvd, Tampa, FL 33614); free shipping on orders over $250; same-day fulfillment from the Tampa facility when cutoffs allow. Observed August 5, 2026.

Watch-out

GLP 1 (S), GLP 2 (T), and GLP 3 (R) are house codes for semaglutide, tirzepatide, and retatrutide; Tesa is tesamorelin. Temporary sale prices are captured separately from the regular list price used on the pricing board, and site-wide purity marketing is not inherited onto sterility or endotoxin panels a report does not run.

A Tampa-fulfilled public catalog with standing per-size prices and a public certificate library whose Janoshik Analytical and Kovera Labs reports resolve at the laboratories’ public verification surfaces.

EVO Labs Research exposes a stock-aware public catalog of research peptides and a public /coa library that publishes current Janoshik Analytical and Kovera Labs batch reports. PeptideBenchmark ranks the regular per-vial list price and treats temporary sale pricing as a separate observed lane.

Testing transparency
Vendor-hosted public documents
Public Verification
Publicly inspectable
Public COA library with Janoshik and Kovera provider verification

The public library publishes vendor-hosted batch reports from Janoshik Analytical and Kovera Labs. PeptideBenchmark confirms printed report codes and task/key pairs against each laboratory’s public verification surface where they resolve. Most current single-vial peptide SKUs have a matched certificate; multi-vial sets, nasal bundles, stacks, topicals, and IU-dosed products stay outside the peptide board. A matched certificate documents the tested sample and does not endorse every vial or unlisted safety panel.

Products reviewed
48
Products with certificates
34
Coverage ratio
71%
Avg certs / covered product
1.79

This vendor is one of 113 names currently included in our manual curated research-vendor layer.

View curated vendor pageView transparency viewView compare page

This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.

  • Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
  • Look for repeated product-level behavior across the catalog, not just one showcase example.
  • Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
Read transparency methodologyBrowse similar transparency patterns

This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.

Open vendor compareOpen vendor/provider bridge

PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.

Strong curated case

EVO Labs is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.

Evidence access
Open public verification
Verification structure
Provider-linked
Evidence depth
Broad
Lab context
Multi-lab or multi-category
Evidence access
Open public verification

Readers can leave the vendor marketing layer and inspect verification publicly.

Verification structure
Provider-linked

This is the strongest public pattern because the verification step routes into an outside provider layer.

Evidence depth
Broad

Current review touched 48 products and 61 document/link destinations.

Lab context
Multi-lab or multi-category

2 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.

How to read this benchmark

This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.

A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.

Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.